Inventor
Sara BUHRLAGE
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07DHeterocyclic compounds27%
A01KAnimal husbandry9%
A61KPreparations for medical, dental or toiletry purposes9%
C07KPeptides9%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms9%
G01NInvestigating or analysing materials by determining their chemical or physical properties9%
PatentTitleYear
12,503,453USP7 inhibition202511,465,983USP7 inhibitors for treating multiple myeloma202211,447,467Compounds for the degradation of STK4 and treatment of hematologic malignancies202211,136,409Compositions and methods for identification, assessment, prevention, and treatment of AML using USP10 biomarkers and modulators2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to DANA FARBER CANCER INST INC (4)· patent assignee history
2021–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| DANA FARBER CANCER INST INC | 4 | 2021–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2021–2025 |